ID   KPCL_HUMAN              Reviewed;         683 AA.
AC   P24723; Q16246; Q8NE03;
DT   01-MAR-1992, integrated into UniProtKB/Swiss-Prot.
DT   15-DEC-2009, sequence version 4.
DT   05-OCT-2010, entry version 115.
DE   RecName: Full=Protein kinase C eta type;
DE            EC=2.7.11.13;
DE   AltName: Full=PKC-L;
DE   AltName: Full=nPKC-eta;
GN   Name=PRKCH; Synonyms=PKCL, PRKCL;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Lung;
RX   MEDLINE=91094824; PubMed=1986216;
RA   Bacher N., Zisman Y., Berent E., Livneh E.;
RT   "Isolation and characterization of PKC-L, a new member of the protein
RT   kinase C-related gene family specifically expressed in lung, skin, and
RT   heart.";
RL   Mol. Cell. Biol. 11:126-133(1991).
RN   [2]
RP   ERRATUM, AND SEQUENCE REVISION.
RX   MEDLINE=92186874; PubMed=1545821;
RA   Bacher N., Zisman Y., Berent E., Livneh E.;
RL   Mol. Cell. Biol. 12:1404-1404(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=22459283; PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 438-539.
RX   MEDLINE=95080426; PubMed=7988719; DOI=10.1016/0014-5793(94)01202-4;
RA   Palmer R.H., Ridden J., Parker P.J.;
RT   "Identification of multiple, novel, protein kinase C-related gene
RT   products.";
RL   FEBS Lett. 356:5-8(1994).
RN   [8]
RP   INTERACTION WITH DGKQ.
RX   PubMed=15632189; DOI=10.1074/jbc.M409301200;
RA   van Baal J., de Widt J., Divecha N., van Blitterswijk W.J.;
RT   "Translocation of diacylglycerol kinase theta from cytosol to plasma
RT   membrane in response to activation of G protein-coupled receptors and
RT   protein kinase C.";
RL   J. Biol. Chem. 280:9870-9878(2005).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-317 AND SER-320, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-57; SER-317 AND SER-675,
RP   AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-317, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 1-138, PHOSPHORYLATION AT
RP   SER-28 AND SER-32, AND MASS SPECTROMETRY.
RX   PubMed=16973127; DOI=10.1016/j.bbrc.2006.08.160;
RA   Littler D.R., Walker J.R., She Y.-M., Finerty P.J. Jr., Newman E.M.,
RA   Dhe-Paganon S.;
RT   "Structure of human protein kinase C eta (PKCeta) C2 domain and
RT   identification of phosphorylation sites.";
RL   Biochem. Biophys. Res. Commun. 349:1182-1189(2006).
RN   [13]
RP   ASSOCIATION OF VARIANT ILE-374 WITH ISCHEMIC STROKE, AND
RP   CHARACTERIZATION OF VARIANT ILE-374.
RX   PubMed=17206144; DOI=10.1038/ng1945;
RA   Kubo M., Hata J., Ninomiya T., Matsuda K., Yonemoto K., Nakano T.,
RA   Matsushita T., Yamazaki K., Ohnishi Y., Saito S., Kitazono T.,
RA   Ibayashi S., Sueishi K., Iida M., Nakamura Y., Kiyohara Y.;
RT   "A nonsynonymous SNP in PRKCH (protein kinase C eta) increases the
RT   risk of cerebral infarction.";
RL   Nat. Genet. 39:212-217(2007).
RN   [14]
RP   VARIANTS [LARGE SCALE ANALYSIS] VAL-19; ARG-65; GLN-149; GLN-359;
RP   ILE-374; ALA-575; ILE-594 AND SER-612.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: This is calcium-independent, phospholipid-dependent,
CC       serine- and threonine-specific enzyme.
CC   -!- FUNCTION: PKC is activated by diacylglycerol which in turn
CC       phosphorylates a range of cellular proteins. PKC also serves as
CC       the receptor for phorbol esters, a class of tumor promoters.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Three specific sites; Thr-513 (activation loop
CC       of the kinase domain), Thr-656 (turn motif) and Ser-675
CC       (hydrophobic region), need to be phosphorylated for its full
CC       activation.
CC   -!- SUBUNIT: Interacts with DGKQ.
CC   -!- TISSUE SPECIFICITY: Most abundant in lung, less in heart and skin.
CC   -!- DOMAIN: The C1 domain, containing the phorbol ester/DAG-type
CC       region 1 (C1A) and 2 (C1B), is the diacylglycerol sensor and the
CC       C2 domain is a non-calcium binding domain.
CC   -!- DISEASE: Defects in PRKCH may be a cause of susceptibility to
CC       ischemic stroke [MIM:601367]; also known as cerebrovascular
CC       accident or cerebral infarction. A stroke is an acute neurologic
CC       event leading to death of neural tissue of the brain and resulting
CC       in loss of motor, sensory and/or cognitive function. Ischemic
CC       strokes, resulting from vascular occlusion, is considered to be a
CC       highly complex disease consisting of a group of heterogeneous
CC       disorders with multiple genetic and environmental risk factors.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. PKC subfamily.
CC   -!- SIMILARITY: Contains 1 AGC-kinase C-terminal domain.
CC   -!- SIMILARITY: Contains 1 C2 domain.
CC   -!- SIMILARITY: Contains 2 phorbol-ester/DAG-type zinc fingers.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M55284; AAA60100.1; -; mRNA.
DR   EMBL; AK290183; BAF82872.1; -; mRNA.
DR   EMBL; AL138996; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL355916; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471061; EAW80801.1; -; Genomic_DNA.
DR   EMBL; BC037268; AAH37268.1; -; mRNA.
DR   EMBL; S74620; AAB32724.1; -; mRNA.
DR   IPI; IPI00184572; -.
DR   PIR; A39666; A39666.
DR   RefSeq; NP_006246.2; -.
DR   UniGene; Hs.333907; -.
DR   PDB; 2FK9; X-ray; 1.75 A; A=1-138.
DR   PDBsum; 2FK9; -.
DR   ProteinModelPortal; P24723; -.
DR   SMR; P24723; 117-266, 239-302, 326-557, 352-683.
DR   DIP; DIP-44588N; -.
DR   IntAct; P24723; 1.
DR   MINT; MINT-3973608; -.
DR   STRING; P24723; -.
DR   PhosphoSite; P24723; -.
DR   PRIDE; P24723; -.
DR   Ensembl; ENST00000332981; ENSP00000329127; ENSG00000027075.
DR   GeneID; 5583; -.
DR   KEGG; hsa:5583; -.
DR   UCSC; uc001xfn.1; human.
DR   CTD; 5583; -.
DR   GeneCards; GC14P061788; -.
DR   HGNC; HGNC:9403; PRKCH.
DR   HPA; CAB001998; -.
DR   HPA; HPA026294; -.
DR   MIM; 601367; phenotype.
DR   MIM; 605437; gene.
DR   PharmGKB; PA33767; -.
DR   eggNOG; prNOG15488; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG108317; -.
DR   InParanoid; P24723; -.
DR   OMA; REFIWGV; -.
DR   BRENDA; 2.7.11.13; 247.
DR   Pathway_Interaction_DB; endothelinpathway; Endothelins.
DR   Pathway_Interaction_DB; nfat_3pathway; Role of Calcineurin-dependent NFAT signaling in lymphocytes.
DR   Pathway_Interaction_DB; txa2pathway; Thromboxane A2 receptor signaling.
DR   Reactome; REACT_14797; Signaling by GPCR.
DR   NextBio; 21652; -.
DR   ArrayExpress; P24723; -.
DR   Bgee; P24723; -.
DR   CleanEx; HS_PRKCH; -.
DR   Genevestigator; P24723; -.
DR   GermOnline; ENSG00000027075; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004697; F:protein kinase C activity; TAS:ProtInc.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; TAS:ProtInc.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR000008; C2_Ca-dep.
DR   InterPro; IPR008973; C2_Ca/lipid-bd_dom_CaLB.
DR   InterPro; IPR018029; C2_membr_targeting.
DR   InterPro; IPR020454; DAG/PE-bd.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR015745; PKC.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR014376; Prot_kin_PKC_delta.
DR   InterPro; IPR002219; Prot_Kinase_C-like_PE/DAG-bd.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   PANTHER; PTHR22985:SF86; PKC; 1.
DR   Pfam; PF00130; C1_1; 2.
DR   Pfam; PF00168; C2; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   PIRSF; PIRSF000551; PKC_delta; 1.
DR   PRINTS; PR00008; DAGPEDOMAIN.
DR   SMART; SM00109; C1; 2.
DR   SMART; SM00239; C2; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF49562; C2_CaLB; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 2.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Complete proteome; Kinase; Metal-binding;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Repeat;
KW   Serine/threonine-protein kinase; Transferase; Zinc; Zinc-finger.
FT   CHAIN         1    683       Protein kinase C eta type.
FT                                /FTId=PRO_0000055705.
FT   DOMAIN       12    113       C2.
FT   DOMAIN      355    614       Protein kinase.
FT   DOMAIN      615    683       AGC-kinase C-terminal.
FT   ZN_FING     171    222       Phorbol-ester/DAG-type 1.
FT   ZN_FING     245    295       Phorbol-ester/DAG-type 2.
FT   NP_BIND     361    369       ATP (By similarity).
FT   ACT_SITE    479    479       Proton acceptor (By similarity).
FT   BINDING     384    384       ATP (By similarity).
FT   MOD_RES      28     28       Phosphoserine; by autocatalysis
FT                                (Probable).
FT   MOD_RES      32     32       Phosphoserine; by autocatalysis
FT                                (Probable).
FT   MOD_RES      57     57       Phosphothreonine.
FT   MOD_RES     317    317       Phosphoserine.
FT   MOD_RES     320    320       Phosphoserine.
FT   MOD_RES     513    513       Phosphothreonine (Probable).
FT   MOD_RES     656    656       Phosphothreonine (Probable).
FT   MOD_RES     675    675       Phosphoserine.
FT   VARIANT      19     19       A -> V (in dbSNP:rs55645551).
FT                                /FTId=VAR_042312.
FT   VARIANT      65     65       K -> R (in dbSNP:rs55737090).
FT                                /FTId=VAR_042313.
FT   VARIANT     149    149       R -> Q (in dbSNP:rs55848048).
FT                                /FTId=VAR_042314.
FT   VARIANT     359    359       R -> Q (in dbSNP:rs55818778).
FT                                /FTId=VAR_042315.
FT   VARIANT     374    374       V -> I (associated with susceptibility to
FT                                ischemic stroke; increases
FT                                autophosphorylation and kinase activity;
FT                                dbSNP:rs2230500).
FT                                /FTId=VAR_034604.
FT   VARIANT     497    497       D -> Y (in dbSNP:rs11846991).
FT                                /FTId=VAR_060736.
FT   VARIANT     575    575       T -> A (in a aLL TEL/AML1+ sample;
FT                                somatic mutation).
FT                                /FTId=VAR_042316.
FT   VARIANT     594    594       T -> I (in a colorectal adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_042317.
FT   VARIANT     612    612       P -> S (in dbSNP:rs34159231).
FT                                /FTId=VAR_042318.
FT   VARIANT     645    645       D -> V (in dbSNP:rs35561533).
FT                                /FTId=VAR_042438.
FT   CONFLICT     96     96       Missing (in Ref. 1; AAA60100).
FT   CONFLICT    109    109       L -> R (in Ref. 1; AAA60100).
FT   CONFLICT    110    110       R -> G (in Ref. 1; AAA60100).
FT   CONFLICT    393    393       Q -> L (in Ref. 1; AAA60100).
FT   CONFLICT    472    472       D -> E (in Ref. 7; AAB32724).
FT   STRAND       12     16
FT   HELIX        26     31
FT   STRAND       43     49
FT   STRAND       70     74
FT   STRAND       82     88
FT   STRAND       96    103
FT   HELIX       105    111
FT   STRAND      116    118
FT   STRAND      133    136
SQ   SEQUENCE   683 AA;  77828 MW;  0A29806CE31912F2 CRC64;
     MSSGTMKFNG YLRVRIGEAV GLQPTRWSLR HSLFKKGHQL LDPYLTVSVD QVRVGQTSTK
     QKTNKPTYNE EFCANVTDGG HLELAVFHET PLGYDHFVAN CTLQFQELLR TTGASDTFEG
     WVDLEPEGKV FVVITLTGSF TEATLQRDRI FKHFTRKRQR AMRRRVHQIN GHKFMATYLR
     QPTYCSHCRE FIWGVFGKQG YQCQVCTCVV HKRCHHLIVT ACTCQNNINK VDSKIAEQRF
     GINIPHKFSI HNYKVPTFCD HCGSLLWGIM RQGLQCKICK MNVHIRCQAN VAPNCGVNAV
     ELAKTLAGMG LQPGNISPTS KLVSRSTLRR QGKESSKEGN GIGVNSSNRL GIDNFEFIRV
     LGKGSFGKVM LARVKETGDL YAVKVLKKDV ILQDDDVECT MTEKRILSLA RNHPFLTQLF
     CCFQTPDRLF FVMEFVNGGD LMFHIQKSRR FDEARARFYA AEIISALMFL HDKGIIYRDL
     KLDNVLLDHE GHCKLADFGM CKEGICNGVT TATFCGTPDY IAPEILQEML YGPAVDWWAM
     GVLLYEMLCG HAPFEAENED DLFEAILNDE VVYPTWLHED ATGILKSFMT KNPTMRLGSL
     TQGGEHAILR HPFFKEIDWA QLNHRQIEPP FRPRIKSRED VSNFDPDFIK EEPVLTPIDE
     GHLPMINQDE FRNFSYVSPE LQP
//
